Rexxolide contains 100 mg/ml of tulathromycin, which is widely used to treat BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, to make it more convenient.
Dechra says Rexxolide has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis.
Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.
"We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition."
Rexxolide is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.
The new programme, which starts in May 2021, will address the fundamental principles underlying cardiac disease, discuss common presentations and review current diagnostic and therapeutic techniques.
Modules are delivered using a range of blended learning techniques, including interactive online lessons, supported by notes and videos.
While studying, delegates will have a module tutor – a recognised veterinary Specialist in their field - and a dedicated programme tutor, who works with individual delegates to support them through the programme.
Delegates can also choose three optional practical attendance sessions covering ECGs, thoracic radiography and echocardiography.
The programme offers a route through to achieving academic qualifications - General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with the International School of Veterinary Postgraduate Studies (ISVPS) and Harper Adams University. Gaining a PgC enables delegates to apply to RCVS for Advanced Practitioner status in the subject.
Course Director Kieran Borgeat BSc BVSc MVetMed CertVC DipACVIM DipECVIM-CA MRCVS, said: "Improve International’s Cardiology DL programme features a diverse array of speakers from a variety of backgrounds, who will bring the latest information about veterinary cardiology to delegates. Our module leaders are world experts in their field so bring a thorough and uniquely engaging approach to the course material. Being able to discuss the topic with them and other course delegates online during each module of teaching during a two-year, in-depth course is a fantastic opportunity to connect with the topic as never before."
David Babington MRCVS, Business Development Director at Improve International, said: “Our cardiology programme has been designed to equip delegates with all of the skills and knowledge they need to confidently investigate, diagnose and treat cardiac patients.
“As we start to look ahead to a time beyond lockdowns, many veterinarians are taking stock and considering the next step in their career. For some, an additional qualification may be part of their plan. By offering a distance learning solution, we can ensure that, wherever in the world they are in practice, they have the opportunity to develop their clinical skills and achieve a postgraduate qualification.”
Registration information can be found here: https://www.improveinternational.com/uk/course/pgc-gpcert-small-animal-cardiology-distance-learning/
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100
The PIC decision marked the conclusion of its investigation into a concern that was raised formally last November involving allegations of bullying at Professor Argyle’s workplace, the University of Edinburgh.
Professor Argyle, who had previously decided to step aside from his JVP and Council duties until the concern was investigated and concluded, said: “Despite this outcome from the PIC discussions, I have now made the challenging decision to stand down from my position at the RCVS. This is to ensure there is no further distraction to the College’s important work and activities and that whoever becomes the next JVP has the full support of Council and RCVS members.
"It is also to reduce the toll this situation has taken on my family, colleagues and students, and on me personally. I am proud and privileged to have served on RCVS Council for nearly ten years and wish it well as it navigates the next chapter in its history."
RCVS President Mandisa Greene said: “I appreciate that this has been an exceptionally difficult situation and very upsetting for all involved.
"I understand why David has taken the difficult decision to stand down from RCVS Council and would like to thank him for his many years of service to the RCVS since joining Council in 2012.
"I would also like to reassure colleagues once again that, throughout, the College has remained firmly committed to following due, proper and fair process in all its regulatory activities."
Following Professor Argyle’s decision to step down, the process for electing a new JVP for the current presidential year will commence.
As Professor Argyle was a Veterinary Schools Council appointee on RCVS Council, it will be for that body to elect a replacement Council member.
Further details will be announced in due course.
Until now, the treatment has only been available in 20 and 40 pack sizes. The new two-tube pack option offers clients a pre-packaged treatment course for one ear.
Dechra Brand Manager Carol Morgan said: “The introduction of a pre-packaged Osurnia treatment course provides a convenient solution to veterinarians treating otitis. Osurnia comes in pre-measured, single-dose tubes of the gel with a soft flexible applicator tip that ensures the dog receives the right dose, every time, all while minimising discomfort for the patient.
"The patented gel formulation provides reassurance that the solution is less likely to be dislodged from the patient’s ear, prolonging the contact of the active medicines directly at the infection site1.
"A treatment plan using Osurnia means that vets can help ensure compliance of treatment. The application of the second dose provides an additional opportunity to assess the patient to ensure it is responding as planned."
Osurnia two-tube packs are available from wholesalers. For more information, visit: www.dechra.com.
The study titled “Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome” included thirty-six client-owned brachycephalic dogs (French bulldogs, pug and English bulldogs) in a prospective, randomised trial.
Antacid treatment (omeprazole (1mg/kg PO q24 hours) and magaldrate (5-10mL/dog PO q8-12 hours)) was randomly prescribed in 18 dogs before and after surgery, while the other 18 dogs did not receive any gastrointestinal medical treatment.
Digestive clinical signs and gastro-oesophageal junction abnormalities (GJA) were assessed and scored at presentation, at the time of surgery and at recheck. GJA were assessed during endoscopy in standard conditions, as well as during endotracheal tube obstruction. All endoscopic procedures were recorded and reviewed by a single, blinded reviewer.
In order to assess whether endotracheal tube obstruction manoeuvre accurately detects GJA, the procedure was also performed during the examination of the gastro-oesophageal junction in a group of 10 control dogs. Control dogs were healthy or had diseases that were not expected to interfere with gastro-oesophageal junction dynamics, and were anaesthetised for independent purposes.
Dr Emilie Vangrinsven, corresponding author for the paper said: "Although results of multivariate analysis failed to demonstrate a direct effect of antacid treatment, a significant interaction between antacid treatment status and improvement of digestive clinical score throughout the endoscopies was present, meaning that treated animals seem to improve faster and have lower clinical scores after surgery than untreated animals. Furthermore, a significant improvement in GJA-obstruction score was present in the treatment group only.
"In contrast to standard endoscopy, the obstruction manoeuvre during endoscopy allowed detection of GJA in dogs, even in the absence of clinical signs. We were concerned that the obstruction manoeuvre may induce false positive results for the diagnosis of dynamic GJA; in the control group, GJA during obstruction manoeuvre were found to be negligible suggesting that this technique does not significantly overestimate the presence of GJA.”
Nicola Di Girolamo, Editor of JSAP said: "Based on this study, antacid treatment administered to brachycephalic dogs undergoing surgery may be beneficial. It should be noted that a direct influence of antacid treatment on digestive clinical and lesion scores could not be significantly demonstrated, which may have been because of the lack of an actual difference, or as a result of the small sample size.”
The full article can be found in the March issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279
Reference
Photo: Professor Ian Ramsey
The Disciplinary Committee took the unusual step of granting an application by the respondent for anonymity, after seeing evidence of a real and immediate threat to the individual’s security if their details were made public.
For the purposes of the hearing, the respondent was therefore referred to as 'X'.
The Committee heard that the individual pleaded guilty in court in 2020 to intentionally and knowingly attempting to communicate with a person under 16 years for the purposes of sexual gratification.
Following this they were sentenced to a two-year probation order, were ordered to register on the Sexual Offences Register for five years; and were made subject to a Sexual Offences Prevention Order for five years.
At the outset of the hearing the individual admitted to all the charges against them and the Committee also noted that there was a certified copy of the conviction available.
The Committee then considered whether the conviction amounted to serious professional misconduct. In considering this, it set out the aggravating factors surrounding the case, these being that there was the risk of actual harm to a minor, that the misconduct was premeditated as the respondent had sent a number of messages via a number of online platforms over several days, that the individual displayed predatory behaviour including sending pictures and making comments of a sexual nature, and that it involved what the respondent believed to be a vulnerable individual, namely a 15-year-old child.
In mitigation, the Committee considered that there had been no actual harm caused to a human or animal in light of the fact that the 15-year-old child, who the respondent believed they were communicating with, was not real. It also took into account that the conduct related to a single isolated incident and that the individual had made open and frank admissions at an early stage.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee was satisfied that the sentence imposed on X, which included X being subject to a Sexual Harm Prevention Order until 2025, resulted in the profession of veterinary nurses being brought into disrepute and, in the Committee’s judgement, public confidence in the profession would be undermined if the Committee did not find that the conviction rendered X unfit to practise as a veterinary nurse.”
In considering the individual’s sanction, the Committee heard from a character witness who said that the respondent’s actions were out of character, that they had a previously long and unblemished career, that they had made full admissions and demonstrated insight, and that they had a low risk of reoffending in the future.
Cerys said: “The Committee accepted that X had been an excellent veterinary nurse and that X’s criminal conduct did not relate to X’s practice as a veterinary nurse. However, in the Committee’s judgement, the aggravating factors outweighed the considerable mitigating factors in this case.”
She added: “The Committee decided that a suspension order was not the appropriate sanction for such a serious offence because it did not reflect the gravity of X’s conduct. In the Committee’s judgement, the wider public interest, that is the maintenance of the reputation of the profession and the College as a regulator, required a sanction of removal from the Register. The Committee considered that X had much mitigation and was clearly a dedicated veterinary nurse but the reputation of the profession was more important than the interests of X.
“Further, the Committee noted that in circumstances where X’s probation order expired in 2022, and where the ancillary orders, a Sexual Harm Prevention Order and a requirement to register on the Sexual Offences Register did not expire until 2025; the only proportionate sanction was to direct the Registrar to remove X’s name from the Register of Veterinary Nurses.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
The poster gives information about common dangers such as:
As well as focusing on common dangers, the poster also reinforces the importance of S.P.E.E.D when dealing with poisoned pets:
Will Peel, Product Manager at TVM UK said: "While most pet owners are mindful of the danger that certain foods and plants can pose, when you’re enjoying the spring sunshine and the long Easter weekend, it can be easy to overlook potential pet hazards. It’s vital to reinforce the dangers that can come with the warmer weather to help protect pets from poisoning which can cause serious illness or worse.’
To get your waterproof poster, contact your local TVM territory manager or email help@tvm-uk.com
The company says it is launching the new slCT after achieving success imaging horses in collaboration with its UK-based clinical trial sites.
The new standing CT scanner has a unique low, flat platform for quick and easy entry and exit of the standing sedated horse.
The system uses a dual-concentric ring design which enables the detector plate to remain very close to the region of interest, thereby improving image quality.
Hallmarq says slCT is a good fit for equine practices wanting to step up to 3D imaging in the evaluation of their lameness cases.
Bell Equine in Kent, Sussex Equine in Ashington, and Berkshire- based Donnington Grove Equine were involved in early trials of novel system.
Dr Elisabetta Giorio from Donnington Grove says slCT complements their sMRI which highlights soft tissue and metabolic changes: “The combination of MRI and CT was a useful tool to have and helped with surgical planning and decision making".
For more information, visit: https://hallmarq.net/
The new line, which is available from veterinary wholesalers, is described as a complete feeding solution with everyday wet and dry food and treats. It is made with a minimum of 95% fresh, organic ingredients from controlled and certified origins, presented in an eco-friendly packaging. This, says Dechra, means it is tasty, nutritious and better for the environment.
The wet diets for cats contains organic chicken or fish whilst the dog food contains organic beef or fish.
The Specific treats are made with more than 80% fresh chicken, beef and pork. Dechra says that in taste tests, nine out of ten cats, and 100% of dogs accepted the treats1.
Dechra highlights that unlike competitor products, which use layers of different plastic in their packaging which cannot be recycled, Specific uses single layers of the same plastic with a gas barrier in between. This makes its dry pet food bags fully recyclable, as well as lighter and stronger than PET/PE laminates of the same thickness2.
Once Specific dry pet food bags have been used and recycled, they can be processed into granules and made into a film which can be used to make new things – including dry pet food bags.
Dechra Brand Manager Claire Morgan said: “The exciting new range of organic food that’s as kind to the environment as it is to pets.
"The Specific organic range provides a new option for owners who are committed to providing their animals with the optimum chance of good health. The tried and trusted Specific brand is already available for vets to stock so this is a useful addition for practices looking to add value to the service they provide to pet owners.
"We have committed to making all of our packaging fully recyclable by 2023, starting with the Specific organic range. As well as providing a more ethical and environmentally sound choice for eco-conscious pet owners, it’s part of Dechra’s ‘Circle of Good’ commitment to reduce our business’ impact on the world.”
For more information visit: www.specific-diets.co.uk.
References
PawSquad, which was founded in 2015 by Diwaker Singh and Radu Georgescu, offers veterinary consultations by video and live text chat in the United Kingdom. IVC says it continue to operate as an autonomous entity within the IVC group.
PawSquad CEO, Dr Mark Boddy MRCVS (pictured right) said: “Our network of experienced veterinarians has already helped many thousands of pets in the UK, providing medical advice, emergency triage and preventive health plans. Being part of IVC will allow us to help even more pets and to continue to work positively and collaboratively with the veterinary profession, as well as expand geographically.”
Stuart Caton, Chief Commercial Officer at IVC Evidensia said: "Telemedicine will support the efforts of the group to make high quality veterinary care more accessible to pet owners, lowering the barriers to engagement with the veterinary profession. It’s an excellent acquisition that will further complement the group as pet services grow and evolve in the future. We are delighted the entire PawSquad team will continue with the business supporting their corporate and private clients as before.”
IVC says the accessibility of the PawSquad service encourages pet owners to seek professional advice earlier and more frequently, with around half of all queries being referred for necessary in-clinic follow-up and otherwise providing much valued reassurance and peace of mind.
The company also says telemedicine is particularly appreciated by cat owners or those with nervous dogs, where the stress of a clinic visit can sometimes result in those pets missing out on veterinary care.
PawSquad Chairman and Founder, Diwaker Singh said: “We are pet lovers and launched PawSquad with the objective of making sure that pet owners have instant 24/7 access to quality pet care, accessible from their homes. Towards this end, PawSquad is a great success. The service has grown significantly, confirming there is a clear need for this service. IVC Evidensia’s extensive network will help the business strengthen and grow to even greater heights.”
The programme includes:
Chris Scudder will also be announcing the successful bids for funding from SAMSoc's new research grant initiative.
Co-organiser Caroline Kisielewicz (pictured right) said: "Despite the trials and tribulations of the ongoing pandemic, we are delighted that the spring SAMSoc meeting has returned this year! We are very excited about the upcoming meeting, which is packed full of great lectures that will stimulate some great talking points. Whilst it won't be the same as being there in person, we hope that everyone will enjoy connecting with colleagues and friends through the virtual world with what promises to be a fantastic event."
The association is also inviting entries now for the next poster/case report competition, details of which can be found at: https://www.samsoc.org/competitions/call-for-spring-2021-poster-entries.
The winning presentation will receive £250, and two runners up will each receive £100.
For the full programme, visit https://www.samsoc.org/meetings/2021-spring-meeting
Registration costs £100 for the day, with a discounted rate at £60 for SAMSoc members (membership costs £29).
To register, visit www.samsoc.org.
In current regional anaesthesia procedures two operators are often needed, with an assistant using 'feel' to inject the anaesthetic solution at the required pressure. This, says the company, means anaesthetic solutions can be injected at unsafe pressures. The new device incorporates a safety system that limits injection pressure, to reduce the risk of nerve injury.
Dr. Federico Corletto, Consultant Anaesthetist from Dick White Referrals said: “By turning regional anaesthesia into a one-person procedure, the technology also removes the challenges of communicating with an assistant regarding subjective injective pressure feel, thus removing the unpredictability of an untrained hand.”
Medovate says the use of ultrasound guided regional anaesthesia is becoming more common practice today, with the technique – which can help provide a higher level of visualisation for the practitioner – increasingly seen as a ‘gold standard’.
However, there are limitations and challenges that are not always present in the practice of adult human medicine. Nerve parathesia, for instance, is harder to ascertain in animals. Small animals such as cats also have increased sensitivity to local anaesthetics when compared with other species, necessitating much lower maximum doses be used.1
Brett Hughes, Homecare & Veterinary Business Manager at Vygon UK, said: "The device infuses at 0.5ml/second, and to vets the technology offers a valuable tool that can control injection small intervals at a time. This allows the veterinary practitioner to titrate appropriately to see the anaesthesia spread around a nerve bundle.
"There are a significant number of regional anaesthesia blocks completed in veterinary practice per annum globally, so potentially this NHS developed device could play a major role in the future of veterinary practice."
For more information, visit: https://www.medovate.co.uk/veterinary/safira-for-veterinary-applications and https://www.vygonvet.co.uk/
Dr Fures was convicted of driving with excess alcohol in the Dublin Criminal Courts of Justice in December 2018.
Later, when renewing his UK RCVS registration, Dr Fures told the RCVS Chief Investigator that on the day of his offence, he'd been on a flight from Frankfurt to Dublin which suffered engine failure, causing the pilot to perform a forced emergency landing in Amsterdam. There, he claimed, the passengers switched to an airworthy plane for the rest of the journey, during which he had several drinks to calm his nerves.
In a remarkably detailed and complex investigation, the RCVS Chief Investigator rang Lufthansa and discovered that the flight had not suffered engine failure and had flown direct from Frankfurt to Dublin without incident.
In May and July 2020, the RCVS Chief Investigator wrote to Dr Fures setting out the result of his investigations and research. In his responses Dr Fures accepted that his memory of the incident was wrong.
At the outset of the hearing Dr Fures made an application to the Committee enter into undertakings to voluntarily remove himself from the UK Register and to not apply to re-join. However, the Committee did not accept these undertakings in part on the basis that he was not of retirement age and intended to continue to practise in Ireland.
The Committee considered that if it were to accept his undertakings, then there would be no judgement or findings that could be passed on to the Veterinary Council of Ireland for consideration via its own disciplinary procedures.
Ian Arundale, chairing the Committee and speaking on its behalf, said: “The Committee decided that this is a case in which the public interest, confidence in the profession, and, potentially, the welfare of animals, demands that there be a full hearing, with determinations made by the Disciplinary Committee."
The Committee then went on to consider the facts of the case.
Dr Fures admitted that he had supplied the RCVS with false information about his conviction for drink driving but denied that this was dishonest at the time that he supplied the information. He accepted that the information he provided was wrong, in that his flight between Frankfurt and Dublin, while delayed by just over an hour, did not have to land in Amsterdam as he had previously claimed.
He said that his false statement was based on misremembering the circumstances and that he had genuinely believed his statement was true at the time it was made to the RCVS. He said that, due to shame over his conviction and the negative impact it had on the life of him and his family, he had created a false memory of the circumstances.
However, the Committee was not persuaded that there was any other explanation in this case, other than that Dr Fures deliberately and dishonestly gave false information to the RCVS, to excuse his behaviour.
The Committee then considered if the admitted and proven charges amounted to serious professional misconduct.
Ian said: “The Committee was of the view that Dr Fures’ actions in dishonestly giving false details to his regulator was serious. While it was the case that there was no actual harm or risk to animals arising out of his conduct, the Committee took into account that the dishonest account was given deliberately.
“In addition, it was sustained, in that it was relied upon and expanded upon on several occasions when the College sought further clarity. Dr Fures had the opportunity to correct the situation, and give the truthful account, but he did not do so. The dishonesty was designed to achieve personal gain to Dr Fures, in that he wished to minimise the actions which the College may take against him, and, in consequence, safeguard his career.
“Dr Fures’ action in dishonestly giving false information to his regulator struck at the heart of his obligation, as a registered professional, to be open and honest with his regulator. This obligation is necessary to allow the College, as regulator, to carry out its crucial and statutory functions in ensuring that it investigates concerns properly.”
In considering the sanction for Dr Fures, the Committee took into account the mitigating factors, including the fact that there were no previous regulatory findings against Dr Fures or any previous conviction for dishonesty, that he had demonstrated remorse for his actions, that there was no actual harm or risk of harm to any animal, that no concerns raised about Dr Fures’ practice, that there was no repetition of the dishonest conduct and that he had demonstrated some insight.
However, in terms of aggravating factors it considered that there was deliberate and sustained dishonesty and that he had sought personal gain as a result of his actions.
After considering various options, the Committee decided that a reprimand and warning as to future conduct was the most appropriate sanction for Dr Fures.
The association says that the day of lectures is mainly targeted at those who are starting on their path of ophthalmology, but old hands may also learn a few new tricks.
Topics will include how to get the most from the ophthalmic examination, diagnostics and what options there are for career growth in our specialty.
There will be live panel discussions to give attendees the opportunity to ask any questions they have.
Tickets costs £100+VAT for BrAVO members, £60+VAT for nurses and interns, and £40+VAT for students.
The deadline for registration is Tuesday 16th March at 5:00pm.
To book your ticket, visit: https://www.eventbee.com/v/bravo-spring-meeting-2021/event?eid=164693974#/tickets
The authors say that study seeks to redress the lack of evidence-based information that has so far been published on the epidemiology and clinical management of non-neoplastic anal sac disorders (ASD).
The study, which was carried out within the RVC’s VetCompass programme, focused especially on identifying breeds with increased or reduced risk of anal sac disorders.
The breeds at greatest risk of an anal sac disorder compared with crossbreeds included Cavalier King Charles spaniel, King Charles spaniel and Cockapoo.
Conversely, breeds at reduced risk included larger breed dogs including Boxer, German Shepherd Dog and Lurcher. Flat-faced (brachycephalic) breeds such as Shih Tzu had 2.6 times the risk for anal sac disorders compared to long-skulled breeds such as Border Collies. Spaniel-types, Dachshund-types and Poodle also showed increased risk for anal sac disease.
The study identified 2,372 anal sac disorder cases from a population of 104,212 dogs attending VetCompass participating practices during 2013.
Other findings included:
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: “During two decades in first opinion practice, anal sac problems in dogs were a routine daily presentation for me. However, when I searched the literature to find evidence on the best way to treat these dogs or even on which breeds were at most risk, there was almost no information available. It seemed back then that only problems that were severe enough to be referred to universities in large numbers were researched.
"As a result, vets in first opinion practice generally had to work out for themselves what seemed to be the best treatment in these cases. It is refreshing now to see research on common problems in dogs under first opinion veterinary care being reported. Owners and vets needs this evidence vitally.”
Anette Loeffler, Associate Professor of Veterinary Dermatology at the RVC and co-author of the paper, said: "This study shines a spotlight on critically important area of veterinary practice: antibiotic usage. Twenty percent of dogs presenting with an anal sac disorder received antibiotics even though diagnostic criteria for anal sac infection or proof of efficacy of antibiotic treatment are lacking.
"At a time when antimicrobial resistance presents one of the biggest threats to human and animal health, this highlights an urgent need for further study of these disorders in order to improve dog welfare but also to help vets in making responsible antibiotic treatment decisions in the interest of public health.”
Compiled by global higher education analysts, QS Quacquarelli Symonds, the rankings provide a comparative analysis on the performance of 14,435 individual university programs, taken by students at 1,452 universities in 86 locations around the world, across 51 academic disciplines and five broad Faculty Areas. The rankings are determined by a range of criteria, including academic reputation, research impact, number of citations, employer reputation and the h-index.
In addition to maintaining a perfect score for the Academic Reputation indicator (100) for a second year running, the RVC saw improvements across every category. Research impact was recognised with the RVC scoring 98.9 in Citations per Paper. This was supported by the 97.5 score for h-index, surpassing 2020’s 96.9.
Rankings for Employer Reputation also increased by 29% since 2020, with the RVC now scoring 83.3.
Professor Stuart Reid, Principal of the RVC, said: "Last year, we made a commitment to redouble our efforts in seeking to regain the top spot in the QS rankings, and I am delighted that we have achieved it. This would be remarkable in normal times but, in the context of COVID-19, it is all the more so and a real tribute to the whole RVC community.
"It is the result of enormous efforts made by all RVC staff and students, and I could not be prouder to be Principal of the RVC. The QS rankings are important for our reputation and international standings. With so many outstanding veterinary schools worldwide and with peer recognition one of the metrics, it is particularly pleasing to be first amongst equals."
The full set of rankings can be found at: https://www.topuniversities.com/subject-rankings/2021
Edited by Philip Lhermette, David Sobel and Elise Robertson, the BSAVA Manual of Canine and Feline Endoscopy and Endosurgery, Second Edition provides a guide for vets who want to practice minimally invasive techniques.
Seven videos have been added to Chapter 12, Rigid Endoscopy: Laparoscopy, which has been expanded to include more detailed step-by-step guidance on laparoscopic spays. The new videos show a laparoscopic ovariectomy in a bitch and a cat, a liver and a pancreatic biopsy in a cat, and cholecystocentesis in a cat.
Chapter 16, An Introduction to Laser Endosurgery also has a new video showing nasopharyngeal stenosis in a cat being treated with lateral laser resection and balloon dilation. The use of lasers improves the quality of surgical interventions and provides a valuable component for veterinary practices that are already making use of endoscopy and endosurgery.
Philip Lhermette said: "As a minimally invasive technique, endoscopy is an important diagnostic and surgical tool for clinicians. Our new videos provide valuable visual guidance to support the manual, helping our members to develop and revise their skillset using the most current techniques.”
You can watch the videos on the BSAVA library: https://www.bsavalibrary.com/content/book/10.22233/9781910443620
To buy a physical copy of the BSAVA Endoscopy Manual, visit: https://www.bsava.com/Shop/Veterinary-books#!prod/8fa461ab-3119-eb11-8100-005056be4acd/curr/GBP, or for a digital version, visit: https://www.bsavalibrary.com/content/book/10.22233/9781910443620.
At the hearing, Dr Crawford made no admissions to the charges against him which involved allegations of: failing to provide adequate and appropriate care; failing to provide adequate clinical histories to another practice in respect of several animals; failing to treat fellow veterinary professionals and other members of staff from another practice with courtesy and respect; failing to maintain adequate clinical records; failing to have in place Professional Indemnity Insurance or equivalent arrangements; and, failing to respond to reasonable requests from the RCVS.
Dr Crawford’s representative drew the Committee’s attention to the fact that Mr Crawford was 71 years old, had no previous disciplinary findings against him and had now ceased practising, including closing his practice premises and notifying his previous clients of the closure.
His representative confirmed that Mr Crawford was fully aware that if his application was accepted, he would no longer be able to practise as a veterinary surgeon or identify as a veterinary surgeon. The Committee also noted that the RCVS had consulted with the complainants who were satisfied with the case being disposed of in this way.
Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “Having weighed the public interest in a hearing with the registrant’s interests, the Committee determined that this is not a case in which the public interest required there to be a full hearing. Protection of the welfare of animals would also not be further served by a full hearing. The Committee decided to accede to the respondent’s application.
"The Committee considered that the adjournment on undertakings served to protect the public interest, confidence in the profession and the welfare of animals.
"The Committee carefully considered the detail of the undertakings. It decided, after due consideration that it would accept the respondent’s undertakings in the terms offered and signed."
The Committee also heard that if Dr Crawford were to apply to re-join the Register at a future point, then the adjourned case would be re-opened and a full, public Disciplinary Committee hearing would be held.
The full documentation for the case can be found at: www.rcvs.org.uk/disciplinary
The charity reports that 2020 was its busiest year ever, with 3,921 calls to its Helpline - a 25% increase over 2019.
Similarly, Vetlife's Health Support service saw a record number of referrals in 2020. There were 190 referrals made over the year, compared to 149 in 2019.
At the same time, the charity says it has seen a decrease in income, putting a strain on its resources. The pledge from the RCVS comes in addition to the annual donation of £100,000 made by the Mind Matters Initiative towards the Health Support service. On top of this, the Mind Matters Initiative also helps to fund other essential running costs for the charity, including the Helpline call directing service and by its contribution to the annual Helpline training for volunteers.
Graham Dick, Vetlife President (pictured right) said: “The last 12 months have brought significant challenges for Vetlife as restrictions in fundraising have combined with a significant uplift in demand for our Vetlife Helpline and Health Support services. Against this background the substantial ongoing financial support provided by the RCVS through MMI, both for the costs of professional mental health support and for the necessary call-handling facilities which underpin our Helpline, continues to be an invaluable contribution to the wellbeing of the veterinary community we serve."
The new vaccine offers 12 months protection when used as a single-dose booster in dogs previously vaccinated with Nobivac(r) KC. It is presented in a 10ml multi-dose vial which can be stored in or out of a refrigerator for 28 days after broaching.
Dogs not previously vaccinated against Bordetella bronchiseptica need two doses administered four weeks apart.
The duration of immunity is 7 months after the primary course and 12 months after a booster with Nobivac(r) Respira Bb. It can also be given 12 months after a primary course in cases where the 7 month dose is missed.
Blaise Scott-Morris, Product Manager, MSD Animal Health said: "Currently only an estimated 1 in 3 vaccinated dogs in the UK are also covered against Bordetella1 so Nobivac(r) Respira Bb offers the chance for practices to re-start the conversation about protection with clients.
"A common barrier to Canine Infectious Respiratory Disease (CIRD) protection, caused by Bordetella, is the belief that it is only necessary for dogs going into kennels, rather than all social dogs. Most dogs meet others however, while out walking, during training, or while attending the vets, and CIRD is infectious even at low levels. Indeed, dogs can be asymptomatic but infectious.
"So, improving protection levels against this disease which is distressing for both the owner and dog, is important in both reducing the risk of outbreaks and the need for antibiotic treatment."
According to the company, trials showed that dogs vaccinated with Nobivac(r) Respira Bb demonstrated a significant reduction in clinical signs of respiratory disease and a reduction in bacterial shedding2. It has also been safely demonstrated in a wide range of breeds3 and has proven efficacy in puppies challenged two weeks after the primary course of vaccination4. It can be given concurrently with many other Nobivac(r) vaccines.
MSD says the new vaccine is most suitable for dogs:
Further information can be found at www.nobivacrespiraBb.co.uk, or contact your MSD Animal Health account manager.
References:
According to the company, the new Avacta Allergy+ offers:
Existing customers will be getting a launch pack this week, which comes with a box of Yorkshire teabags (as that's where Avacta heralds from) and a pack of chocolate biscuits so practice staff can take break whilst they peruse details of the new portfolio and accompanying support materials.
To encourage the reuse of the old Avacta submission boxes, the company is also running a competition where practices can win a £100 Amazon gift voucher if they come up with the most practical and imaginative reuse idea. Full details can be found at avactaanimalhealth.com/news.
For more information visit www.avactaanimalhealth.com.
Veterinary surgeons who want to pay in full must do so before before 1st June 2021. For those UK-practising vets who want to pay the fee in three instalments, the first payment should be received before 1st June, the second payment before 1st October and the final payment before the end of the year.
Any vets who do not pay either the fee in full or the first instalment before 1st June will be removed from the Register. If they want to be restored, they'll need to pay an additional restoration fee as well as the registration fee.
Professor Susan Dawson, RCVS Treasurer, said: “Due to the ongoing disruption to the profession because of the lockdown, we are glad to say that RCVS Council has again approved the ability for members of the profession to pay their fee in instalments and therefore spread the cost during this already difficult year.
"We would like to remind members of the profession that the option to pay in instalments is only available to UK-practising veterinary surgeons. For any UK-practising veterinary surgeons who have a Direct Debit set up but who wish to pay by instalments, please make sure to cancel your Direct Debit as soon as possible."
Payments can be made via the My Account area of the RCVS website (www.rcvs.org.uk/myaccount) where you will also need to confirm that you meet the annual continuing professional development (CPD) requirement and declare any convictions, cautions and/or adverse findings.
Any questions, contact the Registration Department: registration@rcvs.org.uk or 020 7202 0707.
For advice about making payments or submitting a remittance form, contact the Finance Department on finance@rcvs.org.uk or 020 7202 0723.
Further details about paying in instalments can also be found in a series of FAQs at: www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/retention-fee-faqs/
The course offers veterinary surgeons and students six hours of CPD covering the five stages of EBVM and an overview of its evolution.
Users can progress through the six modules in order, or dip in and out of individual sections to deepen their knowledge in particular areas. The course includes a number of practical examples and quizzes, and there's a certificate of completion at the end.
The course can also be used as a reference tool for specific aspects of EBVM, such as how to search the literature effectively.
RCVS Knowledge says the new release of EBVM Learning has been well received by veterinary surgeons and nurses who helped test the course. Lucie Goodwin MRCVS said, simply: “This course is excellent.” Chris Gush, Executive Director of RCVS Knowledge (pictured right), said: “This fresh iteration of our EBVM Learning course is the culmination of a huge amount of committed work from an international network of leaders in EBVM, and we are proud to launch it on our new, accessible platform RCVS Knowledge Learn. The course constitutes an important way in which the charity supports all veterinary practitioners to advance the quality of care they provide through evidence-based veterinary medicine, regardless of their role, location or background.”
EBVM Learning can be accessed for free at http://learn.rcvsknowledge.org/ebvm-learning
The series will start on Sunday February 27th when Katie Ford MRCVS, who is also a life coach, will discuss the benefits of 'gratitude practice' in a 'Facebook Live' session starting at 8:00pm.
Thereafter, there will be a further seven 30-minute sessions:
Liz Barton, co-founder of WellVet, said: "We were blown away by the positive response to the Winter Wellbeing series and want to continue to build more tools and content to help people through what has already been a tough start to 2021. Our emphasis is on simple, practical, accessible tips to improve personal and team wellbeing.”
Emma McAnally, territory manager at Boehringer Ingelheim Animal Health said: “Spring is the ideal time to hit refresh on your mental and physical wellbeing. So we felt that this series will help to shed the winter blues, re-energise the team and offer an opportunity for the veterinary community to come together and take forward positive wellbeing practices. We’re delighted to support WellVet again in bringing this Spring series to life.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.